Health Services Research
Latest posts by Health Services Research (see all)
- Medication Nonadherence: The Role of Cost, Community, and Individual Factors - Aug. 25, 2016
- The Seven Pillars Response to Patient Safety Incidents: Effects on Medical Liability Processes… - Aug. 25, 2016
- Decreasing Malpractice Claims by Reducing Preventable Perinatal Harm - Aug. 23, 2016
- Improving Care Transitions Management: Examining the Role of Accountable Care Organization… - Aug. 23, 2016
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: